Researchers continue to excited about Retatrutide , a novel dual compound showing remarkable outcomes in clinical trials for size management. It works by targeting both pathways : GLP-1 and GIP, that , when engaged , help control cravings and enhance calorie burn. Preliminary reports suggest noteworthy weight loss and potential advantages for indiv